Richard D. Wasnich
Publications by Year
Research Areas
Bone health and osteoporosis research, Bone health and treatments, Bone Metabolism and Diseases, Bone and Joint Diseases, Hip and Femur Fractures
Most-Cited Works
- → Effect of Risedronate on the Risk of Hip Fracture in Elderly Women(2001)1,922 cited
- → Pre-Existing Fractures and Bone Mass Predict Vertebral Fracture Incidence in Women(1991)1,116 cited
- → Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis(1990)957 cited
- → Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age(1998)487 cited
- → Changes in Bone Density and Turnover Explain the Reductions in Incidence of Nonvertebral Fractures that Occur during Treatment with Antiresorptive Agents(2002)454 cited
- → Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women(1999)452 cited
- → Antifracture Efficacy of Antiresorptive Agents Are Related to Changes in Bone Density(2000)402 cited
- → Predicting vertebral fracture incidence from prevalent fractures and bone density among non-black, osteoporotic women(1993)369 cited
- → Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy(1993)355 cited
- → Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women1(2000)337 cited